Literature DB >> 9633958

Transluminal stent-graft repair for pseudoaneurysm of PTFE hemodialysis grafts.

P Rabindranauth1, L Shindelman.   

Abstract

PURPOSE: To report the use of endovascular techniques to treat two cases of nonanastomotic pseudoaneurysm of a bridge graft fistula (BGF). METHODS AND
RESULTS: Two men with fully functional polytetrafluoroethylene (PTFE) BGFs both presented with an enlarging mass adjacent to their arteriovenous shunt. The false aneurysm in both instances was located by ultrasound and confirmed by shunt angiography at the time of surgery. Both fistulas were repaired by transluminally introducing a stented graft composed of a balloon-expandable Palmaz stent covered with a PTFE graft. Completion arteriography confirmed normal flow through the graft with no communication between the lumen and the aneurysmal cavity. Both patients recovered without complications and were discharged on the day of the procedure. Follow-up data reveal that both fistulas remain fully functional up to 5 and 6 months, respectively.
CONCLUSIONS: Endovascular repair using stent-grafts can be a safe and effective method of excluding pseudoaneurysms associated with PTFE BGFs.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9633958     DOI: 10.1583/1074-6218(1998)005<0138:TSGRFP>2.0.CO;2

Source DB:  PubMed          Journal:  J Endovasc Surg        ISSN: 1074-6218


  3 in total

1.  Use of stents for the maintenance of hemodialysis access.

Authors:  Jonathan M Lorenz
Journal:  Semin Intervent Radiol       Date:  2004-06       Impact factor: 1.513

2.  Occlusion of a rapidly expanding hemodialysis graft pseudoaneurysm with placement of a stent graft.

Authors:  Arie Moszkowicz; George Behrens; Sebouh Gueyikian; Nilesh H Patel; Hector Ferral
Journal:  Semin Intervent Radiol       Date:  2007-03       Impact factor: 1.513

3.  Surgical management of aneurismal dilation of vein and pseudoaneurysm complicating hemodialysis arteriovenuos fistula.

Authors:  A Shojaiefard; Z Khorgami; A Kouhi; L Kohan
Journal:  Indian J Surg       Date:  2008-01-28       Impact factor: 0.656

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.